Your session is about to expire
← Back to Search
Blood Pressure Monitoring for Kidney Failure
Study Summary
This trial is testing a new hemodialysis system and monitor in people with end-stage kidney disease. The trial is open label, which means that participants and researchers will know which treatment the participants are receiving. The trial is non-randomized, which means that participants will not be assigned to different groups by chance. The trial is post-market, which means that the new system and monitor have already been approved for use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research endeavor currently have open slots for participants?
"According to clinicaltrials.gov, this trial is still open for enrollment. It was first published on September 22nd 2022 and had an updated version available as of the 30th of that month."
What is the approximate size of this trial's participant pool?
"Affirmative. The clinical trial's availability is confirmed on the clinicaltrials.gov website, which was initially uploaded to on September 22nd 2022 and most recently updated on the thirtieth of September 2022. Currently 10 individuals are being sought from a single medical centre for this experiment."
Share this study with friends
Copy Link
Messenger